CELU (celularity.com) Sof foyda

CELU (celularity.com) - kompaniyaning tovar belgisi

Celularity Inc. AQShda joylashgan yo'ldosh hujayralarini qayta ishlash zavodiga egalik qiladi va biomateriallar ishlab chiqarishning butun siklini nazorat qiladi. Kompaniya hozirda regenerativ tibbiyot sohasida sotuvlarni kengaytirmoqda va daromadlar o'sishini ta'minlash uchun klinik sinovlarni boshlamoqda. ESG standartlarining joriy etilishi bioetika va ma'lumotlar himoyasini ta'minlaydi. Kompaniyaning foyda hajmi bozor dinamikasini aks ettiradi, bunda -0.05 qiymati joriy tendentsiyalarni tahlil qilish uchun asosiy ko'rsatkich vazifasini o'taydi.

CELU (Celularity Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

celularity.com (CELU) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Celularity|CELU - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Celularity Inc.|CELU - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Celularity|CELU - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi celularity.com|CELU - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Celularity Inc.|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Celularity|CELU - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Celularity Inc.|CELU - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Celularity|Shoshilinch likvidlik celularity.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CELU - Sof foyda
Kompaniyaning jamlanma tahlili:Celularity Inc.
Celularity Inc asosiy tovari

Celularity Inc. foydasi buxgalteriya tuzatishlaridan tozalanib, biznes tomonidan kunlik ravishda yaratilgan pul oqimini ifodalaydi. GURU.Markets platformasida Celularity Inc. sof foyda tendentsiyasini tahlil qilish orqali investor biotexnologiya sohasidagi xalqaro hamkorlikni cheklashi, biomateriallar logistikasini buzishi yoki global intellektual mulk himoyasini zaiflashtirishi mumkin bo'lgan geosiyosiy risklarga nisbatan Celularity Inc. moliyaviy barqarorligini kuzatishi mumkin.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Pharming Corp (PHAR) - Sof daromad|NKTR: Sof foyda|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof daromad GOSS (Gossamer Corp)|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|RIGL - Sof foyda|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda ACRS|Kyverna - Sof daromad|Tiziana Life Sciences, Ltd. (TLSA) - Kompaniyaning sof daromadi|CABA: Sof daromad|Yakuniy foyda VTYX (ventyxbio.com)|THTX: Sof foyda|AVTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Eledon|Kompaniya foydasi AGEN (Agenus, Inc)|Sof foyda CLYM|Sof daromad zurabio.com ZURA|aTyr Pharma - Sof daromad|Sof moliyaviy natija Adagene Inc (ADAG)|Ikena Oncology, Inc. - Sof foyda|Shattuck Labs, Inc. (STTK) - Sof daromad|EQ: Sof foyda|Kompaniyaning sof daromadi Connect Biopharma Holdings Limited (CNTB)|Kompaniyaning sof foydasi Immunic Therapeutics|Kompaniyaning sof foydasi ATRA|Sof daromad IFRX (InflaRx N.V.)|Sof foyda X4 Pharmaceuticals, Inc (XFOR)|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|INMB (inmunebio.com) - Soliqdan keyingi foyda|Barinthus Biotherapeutics plc - Sof foyda|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof daromad Edesa Biotech Inc EDSA|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB: Sof daromad|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|APVO - Sof moliyaviy natija|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Vyome Holdings - Sof daromad|Sof foyda Revelation Biosciences Inc REVB|INDP - Kompaniyaning sof foydasi|SCNI (BiondVax Pharmaceuticals) - Kompaniya foydasi|CALI: Sof foyda|Kompaniyaning sof daromadi Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Sof foyda|Sof daromad HOOKIPA (HOOK)|Sof foyda IGMS|ITOS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|tcbiopharm.com - Kompaniyaning sof foydasi|THRD: Sof daromad